title: Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
abstract: Although the use of non-myeloablative stem cell transplantation (NST) reduces the severity of graft-versus-host disease (GVHD), GVHD remains a major complication following allogeneic transplantation. Since following NST in comparison with myeloablative conditioning, higher proportions of host immunohematopoietic cells may persist while donor-derived alloreactive lymphocytes are being infused, thus possibly serving as host antigen presentation for continuous stimulation of donor T cells, we speculated that GVHD may be similarly amplified by conditioning followed by intentional administration of host cells. This hypothesis was tested in a preclinical animal model. Increased incidence of GVHD, higher mortality and increased levels of chimerism were observed in recipients reconstituted with host cells, particularly with non-irradiated spleen cells. Graft-versus-leukemia effect was not impaired by post transplant cell administration. These results suggest that GVHD may be amplified by recipient cell infusion using either irradiated or viable stimulatory host cells, thus possibly explaining in part higher than anticipated incidence of GVHD and rapid displacement of host cells and conversion to 100% donor type cells following NST. Administration of irradiated host antigen-presenting cells post transplantation may thus represent a potential approach for amplification of the alloreactive capacity of donor lymphocytes following stem cell transplantation.
authors.affiliation: Department of Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah - Hebrew University Medical Center, Jerusalem, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Hirshfeld
authors.forename: L
authors.initials: L
authors.lastname: Weiss
authors.forename: J
authors.initials: J
authors.lastname: Kasir
authors.forename: M
authors.initials: M
authors.lastname: Zeira
authors.forename: S
authors.initials: S
authors.lastname: Slavin
authors.forename: M Y
authors.initials: MY
authors.lastname: Shapira
mesh_terms: D000818:Animals; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology* / Q000473:pathology; D020544:Graft vs Leukemia Effect; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D015448:Leukemia, B-Cell / Q000628:therapy; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D023421:Models, Animal; D018183:Transplantation Chimera / Q000033:anatomy & histology; D019172:Transplantation Conditioning / Q000379:methods; D014916:Whole-Body Irradiation